© 2025 - 2026
The Life Science Feed. All rights reserved.
A digital publication from Grá & Mawi Media Co.
Tafasitamab-R-CHOP Boosts Frontline DLBCL Outcomes at ASCO 2026
New data presented at ASCO 2026 indicate that tafasitamab combined with R-CHOP improves outcomes for newly diagnosed DLBCL patients.